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The aim of the present observational study was to investigate the relationships between glycaemic status and levels of oxidative stress and inflam-
mation in well-controlled type 2 diabetes subjects. Metabolic variables (weight, BMI, waist circumference (waist), blood glucose, glycated Hb
(HbA1c), insulin, blood lipids), biomarkers of oxidative stress (8-iso-PGF2a, malondialdehyde, 8-oxo-7,8-dihydro-2
0-deoxyguanosine, formamido
pyrimidine glycosylase-sites, frequency of micronucleated erythrocytes, nitrotyrosine) and inflammatory markers (high sensitivity C-reactive
protein (hsCRP), IL-6, cyclo-oxygenase-catalyzed PGF2a-metabolite) were measured. Fifty-six patients (thirty women and twenty-six men, age
62·3 (SD 7·0) years, HbA1c 6·1 (SD 0·9) %, BMI 28·3 (SD 3·8) kg/m
2, waist 99·6 (SD 11·1) cm) were included in the study. HbA1c (r 0·29,
P¼0·03) and blood glucose (r 0·33, P¼0·01) correlated positively with 8-iso-PGF2a. Positive correlations were also observed between HbA1c
and nitrotyrosine (r 0·42, P¼0·01), waist and hsCRP (r 0·37, P¼0·005), hsCRP and IL-6 (r 0·61, P,0·0001) and between PGF2a-metabolite
and 8-iso-PGF2a (r 0·27, P¼0·048). The present study indicates that glycaemic status is associated with oxidative stress even in subjects with
well-controlled type 2 diabetes. Furthermore, inflammation was more related to abdominal obesity than to glycaemic control. A large number
of biomarkers of oxidative stress and inflammation were investigated, but only a few associations were found between the markers. This could
be due to the fact that none of these biomarkers biosynthesises via similar pathways or simultaneously owing to their diverse nature and origin.
Glycaemic control: Oxidative stress: Inflammation: Diabetes mellitus type 2
Diabetes is a disorder associated with an increased risk of
developing vascular and other health complications. Oxidative
stress and inflammation are the major pathogenetic mechan-
isms considered to be implicated in these complications(1,2).
Subjects with type 2 diabetes have been shown to have
increased levels of lipid peroxidation, oxidative damage to
DNA and protein oxidation(1), presumably caused by an over-
production of free radicals and a decreased antioxidative
defence. Enhanced production of free radicals is related to
hyperglycaemia, insulin resistance and hyperinsulinaemia(3).
High levels of glucose lead to an increased production of
free radicals via different mechanisms such as glucose auto-
oxidation and formation of advanced glycation end products(4).
Besides oxidative stress, inflammation is also implicated
in the development of complications in type 2 diabetes(2).
Cyclo-oxygenase catalyzed PG formation, and subsequently
low-grade inflammation is suggested to be an early event in
the development of type 2 diabetes that is further linked to
oxidative stress(5). Elevated levels of high sensitivity C-reac-
tive protein (hsCRP) and IL-6 are seen in subjects with type
2 diabetes(6), and are also associated with an increased risk
for developing the disease in future(7). However, whether
inflammation and oxidative stress are related to glycaemic
control is still not fully clarified.
The aim of the present observational study was to investi-
gate the relationships between glycaemic control and levels
of oxidative stress and inflammation in subjects with well-con-
trolled type 2 diabetes.
Experimental methods
Subjects and study design
Participants were recruited to take part in an intervention study
with antioxidant supplementation. Baseline results are described
in the present article and results from the intervention study are
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presented elsewhere. Inclusion criteria were age 40–75 years,
type 2 diabetes treated with either diet or diet and oral hypo-
glycaemic medication, glycated Hb (HbA1c) ,10% and
BMI ,35 kg/m2. Exclusion criteria were insulin-dependent
diabetes, known CVD, acute inflammatory, liver, kidney or
thyroid diseases as well as medication or supplementation
that could affect oxidative or inflammatory status. Subjects
gave their written consent to participate in the study. The
study was approved by the Ethical Committee of the Medical
Faculty at Uppsala University, Sweden.
Blood and urine sample were drawn in the morning
after an overnight fast. Body height, weight, waist circum-
ference (waist) and blood pressure were recorded at the
same time.
Laboratory analysis
Blood glucose concentration was analyzed by an enzymatic
technique (HemoCue). HbA1c was analyzed with high perfor-
mance liquid chromatography. Plasma insulin was assayed
with an enzymatic immunological assay (Mercodia, Uppsala,
Sweden) in a Coda Automated EIA Analyzer (Bio-Rad Labora-
tories, Hercules, CA, USA). Serum cholesterol, HDL- choles-
terol and TAG concentrations were analysed by enzymatic
colorimetric methods (Thermo Electron Corporation, Vantaa,
Finland) in a Konelab 20 Clinical Chemistry Analyzer
(Thermo Electron Corporation). LDL- cholesterol was calcu-
lated according to Friedewald(8).
Biomarkers of oxidative stress
Comet assay and 8-oxo-7,8-dihydro-20-deoxyguanosine. A
high-alkaline formamido pyrimidine glycosylase (FPG) version
of the comet assay(9) was used with some modifications. For the
8-oxo-7,8-dihydro-20-deoxyguanosine (8-oxodG) analyses,
DNA was isolated using a cold work-up procedure(10) with
small modifications, followed by enzymatic hydrolysis(11).
The amount of 8-oxodG per undamaged 20-deoxyguanosine
was analysed using on-line electrochemical and uv detection
after separation of the nucleosides with HPLC.
Frequency of micronucleated erythrocytes
A flow cytometry-based micronucleus assay in very young
erythrocytes from humans, transferrin-positive reticulo-
cytes(12), was used. In this micronucleus assay, measuring
the frequency of micronucleus-transferrin-positive reticulo-
cytes (fMN-Trf-Ret), the very young erythrocytes were sepa-
rated from the mature before analysis. The detection limit
was approximately a difference of 0·2 of the background
fMN-Trf-Ret. The background fMN-Trf-Ret was approxi-
mately 1‰.
Malondialdehyde
Plasma malondialdehyde (MDA) concentration was measured
by HPCL and fluorescence detection as earlier described(13).
F2-isoprostanes
Free 8-iso-PGF2a, a major F2-isoprostane in urine, was ana-
lysed by a validated RIA developed by Basu(14). Levels
were adjusted for urinary creatinine concentration.
Nitrotyrosine
Nitrotyrosine was assayed in plasma using a commercially
available enzymatic immunological assay (Bioxytech, Oxis-
Research, Portland, OR, USA).
Biomarkers of inflammation
High-sensitivity C-reactive protein. High-sensitivity C-reac-
tive protein measurement was performed in plasma by a
latex-enhanced reagent (Dade Behring, Deerfield, IL, USA)
with the use of a Behring BN ProSpec analyzer (Dade Behring).
Interleukin-6
IL-6 was analysed in plasma by a high-sensitivity ELISA kit
(IL-6 HS, R&D Systems, Minneapolis, MN, USA). Samples
and standards were pipetted in a microtitre plate coated with
monoclonal antibody against IL-6. After incubation and wash-
ing enzyme substrate solution was pipetted and followed by
anti-IL-6 antibody. The colour reaction was proportional to
the bound IL-6.
Prostaglandin F2a-metabolite
Urinary 15-keto-dihydro-PGF2a, a major metabolite of pri-
mary PGF2a, was analysed, by a validated RIA developed
by Basu(15). Levels were corrected for urinary creatinine
concentration.
Statistical analysis
The statistical software JMP version 3.2 (SAS Institute, Cary,
NC, USA) was used. Probability values ,0·05 were regarded
as statistically significant. The unpaired t test or the Wilcoxon
two-sample test was used to analyse sex differences. The cor-
relation coefficients (Pearson’s or Spearman’s coefficients)
were calculated when analysing correlations.
Results
Clinical characteristic
Fifty-six participants (thirty women and twenty-six men,
forty-eight non-smokers and eight smokers) were included in
the study. Significant differences between sexes were found
for weight (men . women), cholesterol, HDL- and LDL-
cholesterol (women . men), 8-iso-PGF2a and nitrotyrosine
(women . men) and IL-6 (men . women). Smokers had a
higher IL-6 level compared with non-smokers and almost
every biomarker for oxidative stress and inflammation
tended to be higher in smokers. Twenty-one persons were trea-
ted with diet only, thirty-five with the addition of anti-diabetic
medication (sulfonylureas or other insulin-stimulating com-
pounds or/and biguanides). Baseline characteristics are pre-
sented as means and standard deviations: age 62·3 (SD 7·0)
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years; BMI 28·3 (SD 3·8) kg/m2; weight 81·9 (SD 13·8) kg;
waist 99·6 (SD 11·1) cm; systolic blood pressure 143 (SD 14)
mmHg; diastolic blood pressure 78 (SD 9) mmHg; HbA1c
6·1 (SD 0·9)%; fasting blood glucose 7·8 (SD 2·3) mmol/l; insu-
lin 69·3 (SD 40·2) pmol/l; TAG 1·7 (SD 0·9) mmol/l; LDL-
cholesterol 2·9 (SD 0·9) mmol/l; HDL-cholesterol 1·1 (SD
0·2) mmol/l; cholesterol 4·7 (SD 1·0) mmol/l; 8-oxodG/106
dG 0·96 (SD 0·45); FPG-sites 30·2 (SD 15·1) % tail; fMN-
Trf-Ret 0·90 (SD 0·50) ‰; MDA 0·68 (SD 0·08) mmol/l; 8-
iso-PGF2a 0·19 (SD 0·09) nmol/mmol creatinine; nitrotyrosine
245 (SD 401) nmol/l; hsCRP 3·1(SD 4·2) mg/l; IL-6 2·5 (SD
2·2) ng/l; 15-keto-dihydro-PGF2a 0·24 (SD 0·10) nmol/mmol
creatinine.
Relationships between glycaemic control and indicators of
oxidative stress and inflammation
Urinary 8-iso-PGF2a was positively correlated to fasting
blood glucose (r 0·33, P¼0·01) as well as HbA1c (r 0·29,
P¼0·03). In addition, there was a positive correlation between
HbA1c and nitrotyrosine (r 0·43, P¼0·01). A negative corre-
lation was seen between HbA1c and MDA (r 20·32,
P¼0·017). Waist (r 0·37, P¼0·005), BMI (r 0·32, P¼0·016)
and weight (r 0·36, P¼0·006) correlated positively with
hsCRP. Correlations were found between 8-iso-PGF2a and
MDA (r 20·33, P¼0·012), hsCRP and IL-6 (r 0·61,
P,0·0001) and 8-iso-PGF2a and 15-keto-dihydro-PGF2a
(r 0·27, P¼0·048).
Excluding smokers (n 8) from the correlation analyses
decreased power of the study but did not change main results.
No change in main results of correlation analyses was found
when studying the subjects treated with diet only or treated
with diet plus diabetic medication. An exception was a posi-
tive association between FPG-sites and blood glucose (r 0·7,
P¼0·0004) in subjects treated only with diet.
Discussion
The study showed positive associations between glycaemic
control (blood glucose and HbA1c) and urinary 8-iso-PGF2a
and HbA1c and nitrotyrosine, demonstrating a significant bio-
logical relationship between glycaemic control and oxidative
stress. It was also found that abdominal obesity and low-
grade inflammation (hsCRP) were closely related to each
other. Despite the inclusion of a considerable number of bio-
markers of oxidative stress and inflammation, only a few
associations were found among these markers.
To the best of our knowledge, no other study investigating
subjects with type 2 diabetes has reported so many biomarkers
of oxidative stress and inflammation simultaneously. Totally
six different biomarkers for oxidative stress and three for
inflammation were measured in this patient group in order
to clarify the relationships between glycaemic control, oxi-
dative stress and inflammation since the latter are two vital
pathologies that are considered to be the integrated parts of
the metabolic syndrome(6,16).
Glycaemic control related to oxidative stress
The direct relationship between glycaemic control and oxi-
dative stress found in the present study has also been
shown elsewhere. One report described a highly significant
correlation between blood glucose and urinary 8-iso-PGF2a
and a reduction of 8-iso-PGF2a associated with improved
glycaemic control(17). However, there are also investigations
not showing such association(5). These differences could be
explained by various levels of glycaemic control in the
patient groups. The negative correlation between HbA1c
and MDA found in the present study was opposite to
findings by Altomare et al., who observed a positive corre-
lation in patients with type 2 diabetes(17). MDA is generally
considered as a less specific marker of oxidative stress
than the most reliable indicator of oxidative stress, 8-iso-
PGF2a
(18).
As far as we know, the correlation shown between HbA1c
and nitrotyrosine has not been shown elsewhere. However,
the lack of such correlation has been reported previously by
Ceriello et al. (19), who at the same time observed a direct cor-
relation between plasma glucose and nitrotyrosine.
In the present study, we found a lack of associations
between glycaemic control and oxidative stress as measured
by 8-oxodG and FPG-sites. Hinokio et al. (20) reported a posi-
tive correlation between glycaemic control and 8-oxodG (in
urine and blood mononuclear cells) in diabetic subjects,
maybe due to the higher level of HbA1c compared with the
present study. The positive relationship between glucose and
FPG-sites found in the present study in subjects treated with
diet only has also been seen by other investigators(21). To
our knowledge, the present study is the first one investigating
the fMN-Trf-Ret in subjects with type 2 diabetes. Healthy
subjects have earlier been examined(22) with the same
method and showed a similar level of frequency as in the pre-
sent study.
Glycaemic control and inflammation
No correlations were found between markers of glycaemic
control and inflammation in the present study as supported
by Pickup et al. (23) but contradictory to observations by
Ford(24). The association found between diabetes and CRP dis-
appeared when adjusted for BMI and waist, indicating that
inflammation is more related to obesity than features for dia-
betes(5).
The well-known relationship between obesity and low-
grade inflammation was also observed in the present study.
A highly significant correlation between hsCRP and obesity
was found, which also has been shown by others in subjects
with type 2 diabetes(24). A strong association between IL-6
and CRP was also observed in the present study. The positive
correlation between the cyclo-oxygenase-mediated inflamma-
tory marker PGF2a-metabolite and the oxidative stress bio-
marker 8-iso-PGF2a found in the present study has also been
observed by others(5), showing a link between free radical
generation and inflammatory response.
Limitations of study
A limitation of the present study was the absence of a healthy
reference population. Comparisons regarding oxidative stress
and inflammation therefore had to be made with other inves-
tigations but with care since study conditions and method-
ology could differ in many aspects, especially grade of
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glycaemic control and obesity. Furthermore, the present study
did not measure the glucose tolerance or record the diabetes
duration, parameters that could have impact on the investi-
gated relationships between metabolic disorders, oxidative
stress and inflammation in subject with diabetes.
In conclusion, the present study indicated that glycaemic
status was associated with oxidative stress even in well-con-
trolled diabetes subjects. Furthermore, inflammation was
more related to abdominal obesity than to glycaemic control.
The relatively small study group with a well-controlled type
2 diabetes and moderate obesity, giving a narrow range of
HbA1c, blood glucose, waist and BMI, increased the prob-
ability that existing relationships may not have been detected.
In spite of these limitations, interesting relationships were
found.
A large number of biomarkers of oxidative stress and inflam-
mation were investigated, but only a few associations were
found between the markers. This could be due to the fact that
none of these biomarkers biosynthesizes via similar pathways
or simultaneously owing to their diverse nature and origin.
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